午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

化合物 MPO-IN-28,MPO-IN-28
  • 化合物 MPO-IN-28,MPO-IN-28

化合物 MPO-IN-28|T5340|TargetMol

價(jià)格 223 448 738
包裝 1mg 5mg 10mg
最小起訂量 1mg
發(fā)貨地 上海
更新日期 2025-07-28
QQ交談 微信洽談

產(chǎn)品詳情

中文名稱:化合物 MPO-IN-28英文名稱:MPO-IN-28
CAS:37836-90-1品牌: TargetMol
產(chǎn)地: 美國保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
純度規(guī)格: 99.02%產(chǎn)品類別: 抑制劑
貨號: T5340
2025-07-28 化合物 MPO-IN-28 MPO-IN-28 1mg/223RMB;5mg/448RMB;10mg/738RMB 223 TargetMol 美國 Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. 99.02% 抑制劑

Product Introduction

Bioactivity

名稱MPO-IN-28
描述MPO-IN-28 is a novel potent, irreversible Myeloperoxidase (MPO) inhibitor with IC50 of 44 nM.
細(xì)胞實(shí)驗(yàn)To evaluate whether selected compounds exhibited toxicity at the cellular level at concentrations ranging from 0.005 to 50 μM, the colorimetric assay MTT was performed58 in normal human dermal fibroblasts (NHDF). Briefly, cell line was cultured in cell culture flasks, grown, and maintained at 37 °C, 95% humidity, 5% CO2 in fibroblast medium FBM supplemented with 2% fetal bovine serum, 0.1% insulin, rhFGF-B, and gentamicin and amphotericin. NHDF cells were chemically detached with trypsin and seeded in 96-well plates and left to attach for 24 h. Prior to treatment, compounds were dissolved in DMSO at a concentration of 10 mM, and cells were treated with the different concentrations of the compounds diluted in culture medium (5 nM to 50 μM) or left untreated for 72 h. The amount of viable cells was determined through the MTT mitochondrial reduction into formazan by living cells according to previously described.58 The optical density (OD) was measured in a Biorad 680RX plate reader at 570 nm (reference 630 nm), and the OD of the untreated control was normalized as 100% of viable cells, allowing determination of the concentration that inhibited their growth by 50% (IC50).
激酶實(shí)驗(yàn)The assay is based on the production of taurine chloramine produced by the MPO/H2O2/Cl? system in the presence of a selected inhibitor at defined concentration. The reaction mixture contained the following reagents in a final volume of 200 μL: 10 mM phosphate buffer (pH 7.4, 300 mM NaCl), 15 mM taurine, compound to be tested (up to 20 μM), and a fixed amount of recombinant MPO (6.6 μL of MPO batch solution diluted 2.5 times, 40 nM). When necessary, the volume was adjusted with water. This mixture was incubated at 37 °C, and the reaction was initiated with 10.0 μL of H2O2 (100 μM). After 5 min, the reaction was stopped by the addition of 10 μL of catalase (8 units/μL). To determine the amount of taurine chloramine produced, 50 μL of 1.35 mM solution of thionitrobenzoic acid was added and the volume was adjusted to 300 μL with water. Then the absorbance of the solutions was measured at 412 nm with a microplate reader, and the curve of absorbance as a function of inhibitor concentration was plotted. IC50 values were then determined by standard procedures by taking into account the absence of hydrogen peroxide as 100% inhibition and the absence of inhibitors as 0% inhibition.
體外活性5 μM of MPO-IN-28 was added to MPO in the presence of 30 μM of guaiacol. In the absence of H2O2, there was no inhibition of MPO, clearly underlining that MPO-IN-28 is an irreversible mechanism-based inhibitor. MPO-IN-28 inhibits the growth of normal human dermal fibroblast (NHDF) at a concentration (IC50) of 17 μM, which is about 400 times higher than the concentration of the MPO inhibitory effect (0.044 μM).
存儲條件Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
溶解度DMSO : 22.73 mg/mL (98.29 mM), Sonication is recommended.
關(guān)鍵字Myeloperoxidase | MPO-IN-28 | MPOIN28 | MPO IN 28 | MPO | Inhibitor | inhibit | GlutathionePeroxidase | Glutathione Peroxidase
相關(guān)產(chǎn)品Nabumetone | ML-210 | 5-Aminosalicylic Acid | Melatonin | Cefdinir | RSL3 | GSTO1-IN-1 | 4-POBN | AZD8309 | 4-Methylesculetin | ML162 | PF-1355
相關(guān)庫抑制劑庫 | 經(jīng)典已知活性庫 | 已知活性化合物庫 | 氧化還原化合物庫 | 代謝化合物庫 | 抗衰老化合物庫 | 谷氨酰胺代謝化合物庫 | NO PAINS 化合物庫 | 抗氧化化合物庫 | 抗代謝疾病化合物庫 | 共價(jià)抑制劑庫
關(guān)鍵字: MPO-IN-28|TargetMol

公司簡介

TargetMol Chemicals Inc. 總部位于馬薩諸塞州波士頓,致力于為全球生化領(lǐng)域科學(xué)家的研究提供專業(yè)的產(chǎn)品和服務(wù)。TargetMol?品牌的客戶群分布于40多個(gè)國家和地區(qū),已發(fā)展成為全球知名的化合物庫和小分子化合物研究供應(yīng)商。 TargetMol?可提供160多種滿足不同需求的化合物庫,以及多種類型的生化試劑產(chǎn)品,包括12000多種抑制劑、16000多種天然產(chǎn)物和各類多肽、抗體、生命科學(xué)試劑盒等,此外,我們還建設(shè)有CADD(計(jì)算機(jī)輔助藥物設(shè)計(jì))研究中心、藥理實(shí)驗(yàn)室、藥化合成平臺三大技術(shù)中心,全方位滿足客戶的定制需求。 憑借我們優(yōu)質(zhì)的產(chǎn)品和服務(wù)、快速高效的全球供應(yīng)鏈和專業(yè)的技術(shù)支持,我們將有效幫助您縮短研發(fā)周期,取得更成功的結(jié)果。
成立日期 2013-04-18 (13年) 注冊資本 566.265100萬人民幣
員工人數(shù) 100-500人 年?duì)I業(yè)額 ¥ 1億以上
主營行業(yè) 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) 經(jīng)營模式 貿(mào)易,工廠,試劑,定制,服務(wù)
  • TargetMol中國(陶術(shù)生物)
VIP 4年
  • 公司成立:13年
  • 注冊資本:566.265100萬人民幣
  • 企業(yè)類型:有限責(zé)任公司(自然人投資或控股)
  • 主營產(chǎn)品:小分子抑制劑、藥物篩選化合物庫、藥物篩選等
  • 公司地址:靜安區(qū)江場三路238號8樓
詢盤

化合物 MPO-IN-28|T5340|TargetMol相關(guān)廠家報(bào)價(jià)

產(chǎn)品名稱 價(jià)格   公司名稱 報(bào)價(jià)日期
詢價(jià)
上海貝鑫科科技發(fā)展有限公司
2025-07-31
詢價(jià)
VIP3年
陜西西化化學(xué)工業(yè)有限公司
2025-07-29
詢價(jià)
VIP4年
湖北魏氏化學(xué)試劑股份有限公司
2025-07-31
¥146.90
VIP2年
上海阿拉丁生化科技股份有限公司
2025-05-16
內(nèi)容聲明:
以上所展示的信息由商家自行提供,內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由發(fā)布商家負(fù)責(zé)。 商家發(fā)布價(jià)格指該商品的參考價(jià)格,并非原價(jià),該價(jià)格可能隨著市場變化,或是由于您購買數(shù)量不同或所選規(guī)格不同而發(fā)生變化。最終成交價(jià)格,請咨詢商家,以實(shí)際成交價(jià)格為準(zhǔn)。請意識到互聯(lián)網(wǎng)交易中的風(fēng)險(xiǎn)是客觀存在的
主頁 | 企業(yè)會(huì)員服務(wù) | 廣告業(yè)務(wù) | 聯(lián)系我們 | 舊版入口 | 中文MSDS | CAS Index | 常用化學(xué)品CAS列表 | 化工產(chǎn)品目錄 | 新產(chǎn)品列表 |投訴中心
Copyright ? 2008 ChemicalBook 京ICP備07040585號  京公海網(wǎng)安備110108000080號  All rights reserved.